Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Find out which credit cards offer cash rewards without any fees. Make informed choices and enhance your financial benefits.
26,782 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A major stake move by Arnhold LLC in Kyndryl Holdings has turned heads. This article breaks down what the purchase me...
A sharp intraday drop in Micron shares sparked by AI memory demand concerns set off a broader discussion about pricin...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
A Tuesday rally put Tower Semiconductor in the spotlight as investors priced in capacity upgrades and stronger demand...
A single insider trade can spark headlines, but it isn’t a crystal ball. This guide explains how to read a director s...
June market swings have hit chip names hard, but the smarter money is shifting toward a single AI-dominant tech heavy...
A high-yield ETF promises sky-high payouts but posted negative returns over the last year as investors weigh the true...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
SailPoint faced a sharp pullback after its latest results, sparking questions about growth and profitability. This ar...
In mid-2026, the Amplify CWP Enhanced Dividend Income ETF climbs past $5.25 billion in assets as its monthly distribu...